The cannabinoid CB1 receptor antagonist SR141716A...

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats

Antonia Serrano, Ignacio del Arco, Francisco Javier Pavón, Manuel Macías, Vidal Perez-Valero, Fernando Rodríguez de Fonseca
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
54
Year:
2008
Language:
english
DOI:
10.1016/j.neuropharm.2007.03.007
File:
PDF, 354 KB
english, 2008
Conversion to is in progress
Conversion to is failed